Association of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosis

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Yamaji, Kyohei ^a   Kubo, Shunsuke ^b   Inoue, Katsumi ^a   Kadota, Kazushige ^b   Kuramitsu, Shoichi ^a   Shirai, Shinichi ^a   Ando, Kenji ^a   Nobuyoshi, Masakiyo ^a   Mitsudo, Kazuaki ^b   Kimura, Takeshi ^c  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

^b KURASHIKI CENTRAL HOSPITAL   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; HEPARIN; PACLITAXEL; RAPAMYCIN; TICLOPIDINE; UMIROLIMUS; ZOTAROLIMUS; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; ASPIRATION CATHETER; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DRUG ELUTING STENT; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERSENSITIVITY; INFLAMMATORY INFILTRATE; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; STENT MALAPPOSITION; STENT THROMBOSIS; THROMBUS ASPIRATION; VERY ELDERLY; VERY LATE STENT THROMBOSIS; ADVERSE EFFECTS; THROMBOSIS;

AGED; ATHEROSCLEROSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 84913553810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113870     Document Type: Article

References (33)

1. McFadden EP, Stabile E, Regar E, Cheneau E, Ong ATL, et al. (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364: 1519-1521. doi: 10.1016/S0140-6736(04)17275-9.
2. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha S, et al. (2006) Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113: 1108-1113. doi: 10.1161/CIRCULATIONAHA.105.600155.
3. Van Werkum JW, Heestermans AACM, de Korte FI, Kelder JC, Suttorp M-J, et al. (2009) Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation 119: 828-834. doi: 10.1161/CIRCULATIONAHA.108.799403.
4. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, et al. (2012) Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. Circulation 125: 584-591. doi: 10.1161/CIRCULATIONAHA.111.046599.
5. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Jüni P, et al. (2008) Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 52: 1134-1140. doi: 10.1016/j.jacc.2008.07.006.
6. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, et al. (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369: 667-678. doi: 10.1016/S0140-6736(07)60314-6.
7. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, et al. (2014) Late Adverse Events After Implantation of Sirolimus-Eluting Stent and Bare-Metal Stent: Long-Term (5-7 Years) Follow-Up of the Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2. Circ Cardiovasc Interv 7: 168-179. doi: 10.1161/CIRCINTERVENTIONS.113.000987.
8. Doyle B, Rihal CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, et al. (2007) Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 116: 2391-2398. doi: 10.1161/CIRCULATIONAHA.107.707331.
9. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, et al. (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109: 701-705. doi: 10.1161/01.CIR.0000116202.41966.D4.
10. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, et al. (2007) Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115: 2426-2434. doi: 10.1161/CIRCULATIONAHA.106.658237.
11. Lee CW, Kang S-J, Park D-W, Lee S-H, Kim Y-H, et al. (2010) Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 55: 1936-1942. doi: 10.1016/j.jacc.2009.10.077.
12. Pesarini G, Dandale R, Rigamonti A, Pighi M, Zivelonghi C, et al. (2013) Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy. Catheter Cardiovasc Interv 82: 1056-1065. doi: 10.1002/ccd.24938.
13. Kosonen P, Vikman S, Jensen LO, Lassen JF, Harnek J, et al. (2013) Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS). Int J Cardiol 168: 1010-1016. doi: 10.1016/j.ijcard.2012.10.033.
14. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, et al. (2009) Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 120: 391-399. doi: 10.1161/CIRCULATIONAHA.109.854398.
15. Kon H, Sakai H, Otsubo M, Takano H, Okamoto K, et al. (2011) Contrast staining outside the sirolimus-eluting stent leading to coronary aneurysm formation: a case of very late stent thrombosis associated with hypersensitivity reaction. Circ Cardiovasc Interv 4: e1-3. doi: 10.1161/CIRCINTERVENTIONS.110.958090.
16. Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, et al. (2011) Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation 123: 2382-2391. doi: 10.1161/CIRCULATIONAHA.110.003459.
17. Imai M, Kimura T, Morimoto T, Saito N, Shiomi H, et al. (2014) Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: an observation from the multicenter j-Cypher registry PSS substudy. Cardiovasc Interv Ther 29: 226-236. doi: 10.1007/s12928-014-0248-6.
18. Tada T, Kadota K, Hosogi S, Kubo S, Ozaki M, et al. (2012) Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining. Circ Cardiovasc Interv 5: 649-656. doi: 10.1161/CIRCINTERVENTIONS.112.968487.
19. Joner M, Finn A V, Farb A, Mont EK, Kolodgie FD, et al. (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48: 193-202. doi: 10.1016/j.jacc.2006.03.042.
20. Finn A V, Nakazawa G, Joner M, Kolodgie FD, Mont EK, et al. (2007) Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27: 1500-1510. doi: 10.1161/ATVBAHA.107.144220.
21. Nakazawa G, Finn A V, Vorpahl M, Ladich ER, Kolodgie FD, et al. (2011) Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxeleluting stents. J Am Coll Cardiol 57: 390-398. doi: 10.1016/j.jacc.2010.05.066.
22. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, et al. (2011) The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 57: 1314-1322. doi: 10.1016/j.jacc.2011.01.011.
23. Yamaji K, Inoue K, Nakahashi T, Noguchi M, Domei T, et al. (2012) Bare metal stent thrombosis and in-stent neoatherosclerosis. Circ Cardiovasc Interv 5: 47-54. doi: 10.1161/CIRCINTERVENTIONS.111.964965.
24. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, et al. (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115: 2344-2351. doi: 10.1161/ CIRCULATIONAHA.106.685313.
25. Umeda H, Gochi T, Iwase M, Izawa H, Shimizu T, et al. (2009) Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol 133: 321-326. doi: 10.1016/j.ijcard.2007.12.067.
26. Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, et al. (2009) Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol 103: 818-823. doi: 10.1016/j.amjcard.2008.11.051.
27. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, et al. (2001) American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Do. J Am Coll Cardiol 37: 1478-1492.
28. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, et al. (2005) Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 46: 1002-1005. doi: 10.1016/j.jacc.2005.05.068.
29. Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, et al. (2010) Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation. Circulation 122: 52-61. doi: 10.1161/CIRCULATIONAHA.109.903955.
30. Kozuma K, Kimura T, Suzuki N, Miyazawa A, Waseda K, et al. (2013) Peri-stent contrast staining and very late stent thrombosis after sirolimus-eluting stent implantation: an observation from the RESTART (REgistry of Stent Thrombosis for review And Re-evaluaTion) angiographic substudy. EuroIntervention 9: 831-840. doi: 10.4244/EIJV9I7A137.
31. Sonoda S, Okazaki M, Iwataki M, Kashiyama K, Muraoka Y, et al. (2012) Intravascular ultrasound and histopathological observations in a patient with very late sirolimus-eluting stent thrombosis. J Cardiol Cases 6: e126-e129. doi: 10.1016/j.jccase.2012.04.007.
32. Inoue K, Mitsudo K, Nobuyoshi M (2008) Medial necrosis due to sirolimus-eluting stent implantation in human coronary artery. J Cardiol 51: 60-64. doi: 10.1016/j.jjcc.2007.08.001.
33. Park S-J, Park D-W, Kim Y-H, Kang S-J, Lee S-W, et al. (2010) Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med 362: 1374-1382. doi: 10.1056/NEJMoa1001266.